TY - JOUR
T1 - Endovascular therapy for steno-occlusive subclavian and innominate artery disease
T2 - Safety and efficacy at a single center with >20 years’ experience
AU - Bradaric, Christian
AU - Kuhs, Kristin
AU - Groha, Philip
AU - Dommasch, Michael
AU - Langwieser, Nicolas
AU - Haller, Bernhard
AU - Ott, Ilka
AU - Fusaro, Massimiliano
AU - Theiss, Wolfram
AU - Von Beckerath, Nicolas
AU - Kastrati, Adnan
AU - Laugwitz, Karl Ludwig
AU - Ibrahim, Tareq
N1 - Publisher Copyright:
© 2015, Japanese Circulation Society. All rights reserved.
PY - 2015
Y1 - 2015
N2 - Background: This study investigated the safety and outcome of endovascular therapy for steno-occlusive subclavian or innominate artery disease at a single center over a long period of more than 2 decades. Methods and Results: We retrospectively analyzed all endovascular procedures of stenosis or occlusion of the subclavian or innominate artery between January 1990 and October 2013. During the observation period, a total of 130 procedures were attempted in 127 mostly symptomatic patients with stenosis (n=108; 83%) or occlusion (n=22; 17%) of the subclavian (n=119; 92%) and innominate (n=11; 8%) artery. The overall technical success rate was 97.7% (n=127/130). Accounting for the type of lesion, the success rate for stenosis was 100% (n=108/108) and for total occlusion, 86% (n=19/22). The periprocedural complication rate was low and included stroke, transient ischemic attack, and access site complications of 0.8%, 1.5%, and 3.8%, respectively. During a mean follow-up of 28 months the rate of restenosis (>70%) was 12%. Due to the overall low event rate no significant lesion or procedural risk factor for the development of restenosis could be identified. Conclusions: Stenosis and occlusion of the subclavian and innominate artery can be treated safely and successfully by endovascular therapy with excellent long-term patency.
AB - Background: This study investigated the safety and outcome of endovascular therapy for steno-occlusive subclavian or innominate artery disease at a single center over a long period of more than 2 decades. Methods and Results: We retrospectively analyzed all endovascular procedures of stenosis or occlusion of the subclavian or innominate artery between January 1990 and October 2013. During the observation period, a total of 130 procedures were attempted in 127 mostly symptomatic patients with stenosis (n=108; 83%) or occlusion (n=22; 17%) of the subclavian (n=119; 92%) and innominate (n=11; 8%) artery. The overall technical success rate was 97.7% (n=127/130). Accounting for the type of lesion, the success rate for stenosis was 100% (n=108/108) and for total occlusion, 86% (n=19/22). The periprocedural complication rate was low and included stroke, transient ischemic attack, and access site complications of 0.8%, 1.5%, and 3.8%, respectively. During a mean follow-up of 28 months the rate of restenosis (>70%) was 12%. Due to the overall low event rate no significant lesion or procedural risk factor for the development of restenosis could be identified. Conclusions: Stenosis and occlusion of the subclavian and innominate artery can be treated safely and successfully by endovascular therapy with excellent long-term patency.
UR - http://www.scopus.com/inward/record.url?scp=84923447712&partnerID=8YFLogxK
U2 - 10.1253/circj.CJ-14-0855
DO - 10.1253/circj.CJ-14-0855
M3 - Article
C2 - 25746537
AN - SCOPUS:84923447712
SN - 1346-9843
VL - 79
SP - 537
EP - 543
JO - Circulation Journal
JF - Circulation Journal
IS - 3
ER -